These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 23864250

  • 1. A comparison of measured and estimated glomerular filtration rate for carboplatin dose calculation in stage I testicular seminoma.
    Quinton A, Lewis P, Ali P, Morgan C, Bertelli G.
    Med Oncol; 2013; 30(3):661. PubMed ID: 23864250
    [Abstract] [Full Text] [Related]

  • 2. Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.
    Cathomas R, Klingbiel D, Geldart TR, Mead GM, Ellis S, Wheater M, Simmonds P, Nagaraj N, von Moos R, Fehr M.
    Ann Oncol; 2014 Aug; 25(8):1591-7. PubMed ID: 24669017
    [Abstract] [Full Text] [Related]

  • 3. Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula.
    Nagao S, Fujiwara K, Imafuku N, Kagawa R, Kozuka Y, Oda T, Maehata K, Ishikawa H, Koike H, Aotani E, Kohno I.
    Gynecol Oncol; 2005 Nov; 99(2):327-33. PubMed ID: 16005943
    [Abstract] [Full Text] [Related]

  • 4. Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma.
    Shepherd ST, Gillen G, Morrison P, Forte C, Macpherson IR, White JD, Mark PB.
    Eur J Cancer; 2014 Mar; 50(5):944-52. PubMed ID: 24445148
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients.
    Ainsworth NL, Marshall A, Hatcher H, Whitehead L, Whitfield GA, Earl HM.
    Ann Oncol; 2012 Jul; 23(7):1845-53. PubMed ID: 22104575
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients.
    Marx GM, Blake GM, Galani E, Steer CB, Harper SE, Adamson KL, Bailey DL, Harper PG.
    Ann Oncol; 2004 Feb; 15(2):291-5. PubMed ID: 14760124
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.
    de Lemos ML, Hsieh T, Hamata L, Levin A, Swenerton K, Djurdjev O, Vu T, Hu F, Conklin J, Malfair Taylor SC.
    Gynecol Oncol; 2006 Dec; 103(3):1063-9. PubMed ID: 16875719
    [Abstract] [Full Text] [Related]

  • 8. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.
    Okamoto H, Nagatomo A, Kunitoh H, Kunikane H, Watanabe K.
    Cancer Chemother Pharmacol; 1998 Dec; 42(4):307-12. PubMed ID: 9744776
    [Abstract] [Full Text] [Related]

  • 9. Flat dosing of carboplatin is justified in adult patients with normal renal function.
    Ekhart C, de Jonge ME, Huitema AD, Schellens JH, Rodenhuis S, Beijnen JH.
    Clin Cancer Res; 2006 Nov 01; 12(21):6502-8. PubMed ID: 17085665
    [Abstract] [Full Text] [Related]

  • 10. Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey.
    Diminutto A, Basso U, Maruzzo M, Morelli F, De Giorgi U, Perin A, Fraccon AP, Lo Re G, Rizzi A, Sava T, Fornarini G, Valcamonico F, Zustovich F, Massari F, Zanardi E, Roma A, Zattoni F, Zagonel V.
    Clin Genitourin Cancer; 2016 Apr 01; 14(2):e161-9. PubMed ID: 26775721
    [Abstract] [Full Text] [Related]

  • 11. Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing.
    Donahue A, McCune JS, Faucette S, Gillenwater HH, Kowalski RJ, Socinski MA, Lindley C.
    Cancer Chemother Pharmacol; 2001 May 01; 47(5):373-9. PubMed ID: 11391850
    [Abstract] [Full Text] [Related]

  • 12. Carboplatin dosing in the era of IDMS-creatinine; the Cockroft-Gault formula no longer provides a sufficiently accurate estimate of glomerular filtration rate for routine use in clinical care.
    McLean L, Whittle JR, Graham J, Ismail H, Lichtenstein M, Hicks RJ, McNally O, Herschtal A, Rosenthal M, Rischin D, Hamilton A.
    Gynecol Oncol; 2020 Jun 01; 157(3):793-798. PubMed ID: 32220419
    [Abstract] [Full Text] [Related]

  • 13. Use of AUC7 adjuvant carboplatin in patients with stage I seminoma: systematic review of the literature.
    Siracusano S, Diminutto A, Porcaro AB, Cerruto MA, Artibani W.
    Tumori; 2018 Jun 01; 104(2):83-87. PubMed ID: 27791233
    [Abstract] [Full Text] [Related]

  • 14. Carboplatin dosing: gender bias and inaccurate estimates of glomerular filtration rate.
    Dooley MJ, Poole SG, Rischin D, Webster LK.
    Eur J Cancer; 2002 Jan 01; 38(1):44-51. PubMed ID: 11750838
    [Abstract] [Full Text] [Related]

  • 15. Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers.
    Samani A, Bennett R, Eremeishvili K, Kalofonou F, Whear S, Montes A, Kristeleit R, Krell J, McNeish I, Ghosh S, Tookman L.
    ESMO Open; 2022 Apr 01; 7(2):100401. PubMed ID: 35227967
    [Abstract] [Full Text] [Related]

  • 16. Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance.
    White-Koning M, Paludetto MN, Le Louedec F, Gladieff L, Chevreau C, Chatelut E, Puisset F.
    Cancer Chemother Pharmacol; 2020 Mar 01; 85(3):585-592. PubMed ID: 31915969
    [Abstract] [Full Text] [Related]

  • 17. Carboplatin Dosing Accuracy by Estimation of Glomerular Filtration versus Creatinuria in Cancer Patients.
    Graciano Vera N, Pino Villarreal L, Ureña Vargas J.
    Chemotherapy; 2018 Mar 01; 63(3):137-142. PubMed ID: 29768260
    [Abstract] [Full Text] [Related]

  • 18. A comparison of bedside renal function estimates and measured glomerular filtration rate (Tc99mDTPA clearance) in cancer patients.
    Poole SG, Dooley MJ, Rischin D.
    Ann Oncol; 2002 Jun 01; 13(6):949-55. PubMed ID: 12123341
    [Abstract] [Full Text] [Related]

  • 19. Analysis of carboplatin dosing in patients with a glomerular filtration rate greater than 125 mL/min: To cap or not to cap? A retrospective analysis and review.
    Morrow A, Garland C, Yang F, De Luna M, Herrington JD.
    J Oncol Pharm Pract; 2019 Oct 01; 25(7):1651-1657. PubMed ID: 30336729
    [Abstract] [Full Text] [Related]

  • 20. Estimation of glomerular filtration rate in cancer patients.
    Wright JG, Boddy AV, Highley M, Fenwick J, McGill A, Calvert AH.
    Br J Cancer; 2001 Feb 01; 84(4):452-9. PubMed ID: 11207037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.